Results 121 to 130 of about 1,554 (191)

From Mechanisms to Materials: Oximate Reactivity and Emerging Strategies for Organophosphate Detoxification. [PDF]

Chemphyschem
Rodríguez-Dafonte P.
europepmc   +1 more source

Synthesis and Evaluation of Halogenated Pralidoximes in Reactivation of Organophosphate-Inhibited Cholinesterases. [PDF]

ACS Med Chem Lett
Knittelova K, Prchalova E, Fuchsova A, Andrys R, Kohoutova Z, Rademacherova S, Prchal L, Musilek K, Malinak D.   +8 more
europepmc   +1 more source

Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes. [PDF]

Blood Adv
Sallman DA, McLemore AF, Komrokji R, Elmariah H, Kuykendall AT, Bejanyan N, Chan O, Faramand R, Pidala J, Yoder SJ, Perez L, Nishihori T, Padron E, Fernandez H, Lancet JE, Mishra A.   +15 more
europepmc   +1 more source

Functional restoration of conformational (R175H) and contact (R273H) mutant p53 by <i>Bacillus</i>-derived Hydroxymycotrienin A in non-small cell lung cancer: a computational approach. [PDF]

Front Bioinform
Rufus AC, Kumar N S, Ramasamy M, Elangovan E.   +3 more
europepmc   +1 more source

Reactivation by novel pyridinium oximes of rat serum and skeletal muscle acetylcholinesterase inhibited by organophosphates. [PDF]

J Biochem Mol Toxicol
Bennett JP, Meek EC, Chambers JE.
europepmc   +1 more source

Kinetic and structural evidence for specific DMSO interference with reversible binding of uncharged bis-oximes to hAChE and their reactivation kinetics of OP-hAChE. [PDF]

Chem Biol Interact
Kolić D, Gerlits O, Kucharski M, Gorecki L, Joiner N, Kovalevsky A, Radić Z.   +6 more
europepmc   +1 more source

Progress in 1,3-propanediol biosynthesis. [PDF]

Front Bioeng Biotechnol
Li B, Gao W, Pan Y, Yao Y, Liu G.
europepmc   +1 more source

Clinical outcomes of venetoclax combined with hypomethylating agents <i>versus</i> hypomethylating agents alone in <i>TP53</i>-mutated myelodysplastic syndromes. [PDF]

Haematologica
Aldapt M, Wang YH, Shah KJ, El Kettani M, Foran J, Kharfan-Dabaja M, Murthy H, Al-Kali A, Shah MV, Alkhateeb H, Saliba AN, Hogan W, Yi CA, Sproat L, Punwani N, Khera N, Palmer J, Litzow M, Tefferi A, Gangat N, Patnaik MM, Badar T.   +21 more
europepmc   +1 more source

Transplant options and outcomes for TP53 myeloid disease. [PDF]

Hematology Am Soc Hematol Educ Program
Fernández HF, Mishra A.
europepmc   +1 more source

Nanodiamond mediated delivery of pyridinium oxime antidotes to central nervous system for potential treatment of exposure to nerve agents. [PDF]

Chem Biol Interact
Bondar D, Smirnova O, Nagappa NM, Heinmaa I, Soukup O, Kobrlova T, Opravil J, Hrabinova M, Jun D, Starkov P, Spuul P, Kuča K, Mochalin VN, Karpichev Y.   +13 more
europepmc   +1 more source